Australia Stock Exchange release from LIVING CELL TECH : Secures Funds for 3rd Trial of NTCELL in Parkinson Disease
18/10/2021 23:32
Australia Stock Exchange release from LIVING CELL TECH LCT.AX : Secures Funds for 3rd Trial of NTCELL in Parkinson Disease
Recent news on Algorae Pharmaceuticals
See all newsBrief: Algorae Pharmaceuticals Executes License & Supply Agreement With Torrent Pharma
Brief: Algorae Pharmaceuticals And Zydus Enter Exclusive Commercial Agreement
Brief: Algorae Pharmaceuticals Raises A$3.9 Million At A$0.012 Per Share
Brief: Algorae Pharmaceuticals Says TGA Accepts Initial Registration Dossier For Evaluation
Brief: Algorae Pharmaceuticals Partners With Peter Maccallum Cancer Centre For Second AI-Driven Drug Synergy Screening Program